All Stories

  1. Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy
  2. Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth
  3. Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
  4. Endoscopic-assisted maxillectomy: our experience in tumours affecting the posterior wall of the maxillary sinus
  5. Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy
  6. Relación de la infección por el virus del papiloma humano con la aparición de segundas neoplasias y su repercusión pronóstica en los pacientes con carcinoma de orofaringe
  7. Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy
  8. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results
  9. Análisis de la supervivencia de los pacientes con tumores malignos de cabeza y cuello diagnosticados durante la pandemia de COVID-19
  10. Survival of patients with malignant head and neck tumors diagnosed during the COVID-19 pandemic
  11. PATH classification: a proposal for patients with HNSCC treated with salvage surgery
  12. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma
  13. Results of surgical treatment of lymph node metastases in patients with cutaneous squamous cell carcinoma of the head and neck
  14. Descending necrotizing mediastinitis: key points to reduce the high associated mortality in a consecutive case series
  15. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma
  16. Surgical treatment of 186 sinonasal inverted papillomas and analysis of the immunohistochemical and molecular features associated with recurrences
  17. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma
  18. External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
  19. Oncological results of salvage treatment in patients with oropharynx carcinoma treated with radiotherapy
  20. Host-related indexes in head and neck cancer
  21. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy
  22. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas
  23. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
  24. Is long-term screening for lung cancer justified in patients with head and neck carcinoma?
  25. Association between maximum standarised uptake value (SUV) and local control in patients with oropharyngeal carcinoma treated with radiotherapy
  26. Results of radiotherapy in oropharyngeal carcinomas
  27. Facial nerve palsy following parotid gland surgery: A machine learning prediction outcome approach
  28. Differential characteristics of patients with squamous cell carcinoma of the head and neck with no history of tobacco or alcohol use
  29. External validation of the H‐index (host index) in patients with head and neck squamous cell carcinomas
  30. Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
  31. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma
  32. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
  33. The extended SCIP flap: an anatomical and clinical study of a new SCIP flap design
  34. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC
  35. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
  36. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
  37. Pharyngocutaneous fistula in irradiated patients: systematic review and our experience
  38. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy
  39. Causes of long-term mortality in patients with head and neck squamous cell carcinomas
  40. Anatomic mapping of the collateral branches of the external carotid artery with regard to daily clinical practice
  41. Capacidad predictiva de la expresión de IL-8 en pacientes con carcinomas escamosos de cabeza y cuello tratados con radioterapia o quimio-radioterapia
  42. Differential Characteristics of Patients With Squamous Cell Carcinoma of the Head and Neck According to Gender
  43. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy
  44. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population
  45. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors
  46. COVID-19 Pandemic and its Impact on the Management of Head and Neck Cancer in the Spanish Healthcare System.
  47. The carotid axis revisited
  48. Head and neck squamous cell carcinoma in cigar smokers. Distinctive epidemiological and prognostic characteristics
  49. Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy
  50. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas
  51. Preservación de órgano en pacientes con tumores avanzados de laringe. Resultados de la quimioterapia de inducción versus quimio-radioterapia en la práctica clínica real
  52. Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
  53. Trends in disease-specific survival of head and neck squamous cell carcinoma patients treated in a single institution over a 30-year period
  54. The Effect of Perioperative Blood Transfusions on Microvascular Anastomoses
  55. The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients
  56. Resultados oncológicos del tratamiento de rescate en pacientes con carcinomas de hipofaringe
  57. Prognostic capacity of the weighted lymph node ratio in head and neck squamous cell carcinoma patients treated with salvage neck dissection
  58. Preservación de órgano tras un tratamiento con quimioterapia de inducción en pacientes con carcinomas localmente avanzados (T3-T4) de cavidad oral y orofaringe
  59. Salvage surgery in head and neck cancer: External validation of predictors of disease-specific survival
  60. Traqueotomía en pacientes COVID-19: un procedimiento necesario de alto riesgo. Experiencia de dos centros
  61. Capacidad pronóstica de la densidad ganglionar en los carcinomas escamosos de cabeza y cuello
  62. Un caso de sialometaplasia necrosante
  63. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial
  64. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe
  65. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC
  66. Oral cavity colon adenocarcinoma metastases: case report with surgical approach and review of more than 30 years literature
  67. Pharyngeal closure after a total laryngectomy: mechanical versus manual technique
  68. Significado pronóstico de los niveles de albúmina previos al tratamiento en los pacientes con carcinoma escamoso de cabeza y cuello
  69. Valoración de la capacidad pronóstica de la afectación ganglionar de los pacientes con carcinoma de orofaringe en función del estatus HPV
  70. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV ‐negative head and neck squamous cell carcinoma patients
  71. Análisis de la supervivencia específica y el control local mediante un análisis de partición recursiva en pacientes con carcinomas de cabeza y cuello
  72. Does age influence disease‐specific survival in patients with squamous cell carcinomas of the head and neck?
  73. Resultados oncológicos de la laringectomía de rescate en pacientes con carcinomas escamosos de laringe
  74. Riesgo de aparición de segundas neoplasias y neoplasias sucesivas en pacientes con un tumor índice de cabeza y cuello
  75. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer
  76. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma
  77. Pacientes con carcinoma localmente avanzado de hipofaringe. Resultados a lo largo de un periodo de 30 años
  78. Infección parotídea por Mycobacterium malmoense
  79. Características epidemiológicas de los pacientes con carcinomas escamosos de cabeza y cuello. Resultados de un registro hospitalario
  80. Absence of disruptive TP53 mutations in high‐risk human papillomavirus‐driven neck squamous cell carcinoma of unknown primary
  81. Indications and results of extended total laryngectomy with en-bloc resection of overlying cervical skin
  82. Repair of post-laryngectomy pharyngocutaneous fistulas using a pectoralis major flap
  83. The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes
  84. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status
  85. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma
  86. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
  87. Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
  88. Pharyngocutaneous fistula after total laryngectomy: multivariate analysis of risk factors and a severity-based classification proposal
  89. Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy
  90. Carcinoma análogo del secretor mamario de glándulas salivales: a propósito de un caso clínico
  91. Significado pronóstico de la extensión extranodal en pacientes con carcinomas escamosos de cabeza y cuello cN0 con metástasis ganglionares ocultas
  92. HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients’ survival
  93. Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma
  94. Impacto de la laringectomía total en la situación laboral
  95. Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients
  96. Postoperative staging of the neck dissection using extracapsular spread and lymph node ratio as prognostic factors in HPV-negative head and neck squamous cell carcinoma patients
  97. Prognostic value of CD45 transcriptional expression in head and neck cancer
  98. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results
  99. Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM Classification of Malignant Tumors
  100. Modifications in the treatment of advanced laryngeal cancer throughout the last 30 years
  101. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma
  102. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol
  103. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
  104. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area
  105. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma
  106. Nodules en cavité orale, pharynx et larynx
  107. Oral cavity, pharynx and larynx nodules
  108. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer
  109. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients
  110. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
  111. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma
  112. Management of recurrent head and neck cancer: variables related to salvage surgery
  113. Expresión de Heat Shock Protein-90 (HSP-90) como factor predictor de la respuesta a radioterapia en pacientes con tumores de cabeza y cuello
  114. Classification of parotidectomies: a proposal of the European Salivary Gland Society
  115. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
  116. External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma
  117. CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma
  118. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
  119. Reconstrucción de defectos de cavidad oral con colgajos tipo FAMM (colgajo músculo-mucoso de arteria facial). Nuestra experiencia
  120. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
  121. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy
  122. Tratamiento quirúrgico de los carcinomas escamosos de cabeza y cuello en España durante el periodo 2006-2011
  123. Management of Sinonasal Mucosal Melanomas and Comparison of Classification Staging Systems
  124. Parotid Incidentaloma Identified by Positron Emission/Computed Tomography: When to Consider Diagnoses Other than Warthin Tumor
  125. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy
  126. Stomal recurrence in head and neck cancer patients with temporary tracheostomy
  127. Reply to letter to the editor
  128. Etiología y tratamiento de la parálisis laríngea: estudio retrospectivo de 108 pacientes
  129. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
  130. High RAB 25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma
  131. Elective treatment of the neck for second primary tumors of the head and neck
  132. Adherencia crónica al humidificador de traqueostoma en pacientes laringectomizados
  133. Inclusion of Extracapsular Spread in the pTNM Classification System
  134. Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy
  135. Endonasal Endoscopic Scalpel-Forceps Dacryocystorhinostomy vs Endocanalicular Diode Laser Dacryocystorhinostomy
  136. Delayed carotid blow-out syndrome: a new complication of chemoradiotherapy treatment in pharyngolaryngeal carcinoma
  137. Prognostic factors in head and neck squamous cell carcinoma: Comparison of CHAID decision trees technology and cox analysis
  138. Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
  139. Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy
  140. Comparison of Chi-Squared Automatic Interaction Detection Classification Trees vs TNM Classification for Patients With Head and Neck Squamous Cell Carcinoma
  141. Second, third, and fourth head and neck tumors. A progressive decrease in survival
  142. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2
  143. Sarcomas de cabeza y cuello. Nuestra experiencia
  144. Total or subtotal glossectomy with microsurgical reconstruction: Functional and oncological results
  145. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation
  146. Extended deep inferior epigastric artery perforator flap for head and neck reconstruction: A clinical experience with 100 patients
  147. Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy
  148. Risk of third and fourth tumors in patients with head and neck cancer
  149. Management of Sinonasal Inverted Papillomas and Comparison of Classification Staging Systems
  150. Parotidectomías en tumores benignos: clasificación «Sant Pau» de la extensión de la resección
  151. Tratamiento endoscópico combinado vs. abierto en el divertículo de Zenker
  152. Treatment results for ethmoid sinus carcinoma
  153. Resultados de un protocolo de preservación de órgano en pacientes con tumores localmente avanzados de la laringe
  154. Ceratocricoid muscle: An embryological and anatomical study
  155. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case–control study
  156. Prostaglandin E2pathway in head and neck squamous cell carcinoma
  157. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer
  158. Colgajo de pectoral mayor
  159. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies
  160. Trasplante de la laringe: ¿una opción terapéutica para el siglo XXI? Revisión de la literatura
  161. Potential Structures That Could Be Confused With a Nonrecurrent Inferior Laryngeal Nerve: An Anatomic Study
  162. Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification
  163. Modalidades de preservación de órgano en carcinomas de laringe e hipofaringe
  164. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy
  165. Supracricoid laryngectomy as salvage surgery after failure of radiation therapy
  166. Organ Preservation in Laryngeal and Hypopharyngeal Cancer
  167. A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy
  168. Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas
  169. Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma
  170. Incidence and Significance of Clinically Unsuspected Thyroid Tissue in Lymph Nodes Found During Neck Dissection in Head and Neck Carcinoma Patients
  171. Variability in Nerve Patterns of the Adductor Muscle Group Supplied by the Recurrent Laryngeal Nerve
  172. Laryngeal cancer in non-smoking and non-drinking patients
  173. Is dissection of level V necessary in patients with T2–T4N0 supraglottic cancer?
  174. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma
  175. Variability of the Nerve Supply Patterns of the Human Posterior Cricoarytenoid Muscle
  176. Is the External Laryngeal Nerve an Exclusively Motor Nerve? The Cricothyroid Connection Branch
  177. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy
  178. Second Primary Tumors in Head and Neck Cancer Patients
  179. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy
  180. Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: A therapeutic option for the no neck
  181. An anatomical study of anastomoses between the laryngeal nerves
  182. Foramen Thyroideum: A Comparative Study in Embryos, Fetuses, and Adults